NASDAQ:OPTN - OptiNose News Headlines

$6.49
+0.15 (+2.37 %)
(As of 08/21/2019 04:00 PM ET)
Today's Range
$6.00
Now: $6.49
$6.61
50-Day Range
$4.68
MA: $6.18
$8.00
52-Week Range
$4.44
Now: $6.49
$15.73
Volume143,416 shs
Average Volume183,756 shs
Market Capitalization$268.92 million
P/E RatioN/A
Dividend YieldN/A
Beta0.9

Headlines

OptiNose (NASDAQ OPTN) News Headlines

Source:
DateHeadline
OptiNose Inc (NASDAQ:OPTN) Short Interest Up 5.8% in JulyOptiNose Inc (NASDAQ:OPTN) Short Interest Up 5.8% in July
www.americanbankingnews.com - August 16 at 1:38 PM
Zacks: Brokerages Anticipate OptiNose Inc (NASDAQ:OPTN) Will Announce Quarterly Sales of $8.89 MillionZacks: Brokerages Anticipate OptiNose Inc (NASDAQ:OPTN) Will Announce Quarterly Sales of $8.89 Million
www.americanbankingnews.com - August 16 at 4:02 AM
OptiNose Inc to Post Q3 2019 Earnings of ($0.70) Per Share, Piper Jaffray Companies Forecasts (NASDAQ:OPTN)OptiNose Inc to Post Q3 2019 Earnings of ($0.70) Per Share, Piper Jaffray Companies Forecasts (NASDAQ:OPTN)
www.americanbankingnews.com - August 15 at 5:44 AM
Brokers Offer Predictions for OptiNose Incs Q3 2019 Earnings (NASDAQ:OPTN)Brokers Offer Predictions for OptiNose Inc's Q3 2019 Earnings (NASDAQ:OPTN)
www.americanbankingnews.com - August 15 at 5:44 AM
OptiNose (NASDAQ:OPTN) Given a $20.00 Price Target by Royal Bank of Canada AnalystsOptiNose (NASDAQ:OPTN) Given a $20.00 Price Target by Royal Bank of Canada Analysts
www.americanbankingnews.com - August 14 at 5:39 PM
 Analysts Expect OptiNose Inc (NASDAQ:OPTN) to Announce -$0.74 EPS Analysts Expect OptiNose Inc (NASDAQ:OPTN) to Announce -$0.74 EPS
www.americanbankingnews.com - August 14 at 9:39 AM
OptiNoses Q2 Results Reflect Strong Underlying Trends, RBC SaysOptiNose's Q2 Results Reflect Strong Underlying Trends, RBC Says
www.benzinga.com - August 13 at 4:30 PM
50 Stocks Moving In Tuesdays Mid-Day Session50 Stocks Moving In Tuesday's Mid-Day Session
feeds.benzinga.com - August 13 at 1:21 PM
OptiNose, Inc. (OPTN) Q2 2019 Earnings Call TranscriptOptiNose, Inc. (OPTN) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 13 at 12:23 PM
BMO Capital Markets Lowers OptiNose (NASDAQ:OPTN) Price Target to $24.00BMO Capital Markets Lowers OptiNose (NASDAQ:OPTN) Price Target to $24.00
www.americanbankingnews.com - August 13 at 10:13 AM
OptiNose (NASDAQ:OPTN) Posts  Earnings Results, Beats Expectations By $0.08 EPSOptiNose (NASDAQ:OPTN) Posts Earnings Results, Beats Expectations By $0.08 EPS
www.americanbankingnews.com - August 13 at 7:51 AM
Optinose Reports Second Quarter 2019 Financial Results and Recent Operational HighlightsOptinose Reports Second Quarter 2019 Financial Results and Recent Operational Highlights
finance.yahoo.com - August 12 at 9:14 PM
OptiNose (OPTN) Reports Q2 Loss, Lags Revenue EstimatesOptiNose (OPTN) Reports Q2 Loss, Lags Revenue Estimates
finance.yahoo.com - August 12 at 9:14 PM
OptiNose EPS beats by $0.08, beats on revenueOptiNose EPS beats by $0.08, beats on revenue
seekingalpha.com - August 12 at 4:13 PM
Optinose Reports Second Quarter 2019 Financial Results and Recent Operational HighlightsOptinose Reports Second Quarter 2019 Financial Results and Recent Operational Highlights
finance.yahoo.com - August 12 at 4:13 PM
Analysts Estimate OptiNose (OPTN) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate OptiNose (OPTN) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - August 5 at 4:45 PM
OptiNose (OPTN) to Release Earnings on MondayOptiNose (OPTN) to Release Earnings on Monday
www.americanbankingnews.com - August 5 at 11:23 AM
OptiNose Inc (NASDAQ:OPTN) Receives Average Rating of "Buy" from BrokeragesOptiNose Inc (NASDAQ:OPTN) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - August 4 at 2:36 AM
Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019
finance.yahoo.com - August 1 at 9:39 PM
OptiNose Inc (NASDAQ:OPTN) Sees Significant Increase in Short InterestOptiNose Inc (NASDAQ:OPTN) Sees Significant Increase in Short Interest
www.americanbankingnews.com - July 28 at 6:43 PM
Those Who Purchased OptiNose (NASDAQ:OPTN) Shares A Year Ago Have A 73% Loss To Show For ItThose Who Purchased OptiNose (NASDAQ:OPTN) Shares A Year Ago Have A 73% Loss To Show For It
finance.yahoo.com - July 11 at 4:29 PM
Optinose Named a 2019 Best Place to Work by Philadelphia Business JournalOptinose Named a 2019 Best Place to Work by Philadelphia Business Journal
finance.yahoo.com - June 19 at 11:31 PM
OptiNose, Inc. 2019 Q1 - Results - Earnings Call SlidesOptiNose, Inc. 2019 Q1 - Results - Earnings Call Slides
seekingalpha.com - May 12 at 3:43 PM
OptiNose, Inc. (OPTN) CEO Peter Miller on Q1 2019 Results - Earnings Call TranscriptOptiNose, Inc. (OPTN) CEO Peter Miller on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 11 at 11:39 AM
Optinose Reports First Quarter 2019 Financial Results and Recent Operational HighlightsOptinose Reports First Quarter 2019 Financial Results and Recent Operational Highlights
www.globenewswire.com - May 9 at 11:52 AM
OptiNose beats by $0.01, beats on revenueOptiNose beats by $0.01, beats on revenue
seekingalpha.com - May 9 at 11:52 AM
OptiNose (OPTN) Reports Q1 Loss, Tops Revenue EstimatesOptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 9 at 11:52 AM
OptiNose, Inc. (OPTN) Q1 2019 Earnings Call TranscriptOptiNose, Inc. (OPTN) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 9 at 11:52 AM
OptiNose (OPTN) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseOptiNose (OPTN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
www.nasdaq.com - May 2 at 4:18 PM
OptiNose (OPTN) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseOptiNose (OPTN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - May 2 at 11:51 AM
Have Insiders Been Buying OptiNose, Inc. (NASDAQ:OPTN) Shares?Have Insiders Been Buying OptiNose, Inc. (NASDAQ:OPTN) Shares?
finance.yahoo.com - April 27 at 11:27 AM
Optinose to Report First Quarter 2019 Financial Results and Corporate Updates on May 9, 2019Optinose to Report First Quarter 2019 Financial Results and Corporate Updates on May 9, 2019
finance.yahoo.com - April 25 at 11:34 AM
OptiNose Analysts Projects Prescription Growth In 2019, BeyondOptiNose Analysts Projects Prescription Growth In 2019, Beyond
finance.yahoo.com - March 21 at 4:12 PM
Optinose Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational HighlightsOptinose Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Highlights
globenewswire.com - March 6 at 11:32 AM
 Optinose Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Highlights Optinose Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Highlights
finance.yahoo.com - March 6 at 11:32 AM
Optinose to Report Fourth Quarter 2018 Financial Results and Corporate Updates on March 6, 2019Optinose to Report Fourth Quarter 2018 Financial Results and Corporate Updates on March 6, 2019
finance.yahoo.com - February 27 at 12:09 PM
Optinose to Highlight Data at the 2019 AAAAI Annual Meeting in San FranciscoOptinose to Highlight Data at the 2019 AAAAI Annual Meeting in San Francisco
finance.yahoo.com - February 15 at 12:06 PM
Bucks County drug-device developer inks licensing deal worth a potential $45MBucks County drug-device developer inks licensing deal worth a potential $45M
finance.yahoo.com - February 4 at 3:55 PM
Optinose out-licenses EDS technology to Inexia for up to $45MOptinose out-licenses EDS technology to Inexia for up to $45M
seekingalpha.com - February 4 at 8:19 AM
Optinose Announces License AgreementOptinose Announces License Agreement
finance.yahoo.com - February 4 at 8:19 AM
OptiNose Inc.OptiNose Inc.
www.barrons.com - December 31 at 3:55 PM
OptiNose, Inc. (NASDAQ:OPTN): Time For A Financial Health CheckOptiNose, Inc. (NASDAQ:OPTN): Time For A Financial Health Check
finance.yahoo.com - December 25 at 3:55 PM
The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With BiogenThe Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen
finance.yahoo.com - December 13 at 4:12 PM
Optinose Announces Update to License Agreement with Avanir Pharmaceuticals for ONZETRA XSAILOptinose Announces Update to License Agreement with Avanir Pharmaceuticals for ONZETRA XSAIL
www.nasdaq.com - December 11 at 11:09 AM
Avanir terminates license deal with Optinose for intranasal migraine medAvanir terminates license deal with Optinose for intranasal migraine med
seekingalpha.com - December 11 at 11:09 AM
Optinose enrolls first patient in clinical trial of XHANCE for chronic sinusitisOptinose enrolls first patient in clinical trial of XHANCE for chronic sinusitis
seekingalpha.com - December 10 at 10:45 AM
Optinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic SinusitisOptinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic Sinusitis
finance.yahoo.com - December 10 at 10:45 AM
Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare ConferenceOptinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
finance.yahoo.com - December 6 at 10:03 AM
Is OptiNose, Inc. (NASDAQ:OPTN) A Good Stock To Buy?Is OptiNose, Inc. (NASDAQ:OPTN) A Good Stock To Buy?
finance.yahoo.com - November 27 at 10:59 AM
OptiNose, Inc. (OPTN) CEO Peter Miller on Q3 2018 Results - Earnings Call TranscriptOptiNose, Inc. (OPTN) CEO Peter Miller on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 4:01 PM
This page was last updated on 8/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel